GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS

被引：185
作者：
CLARK, DWJ
机构：
来源：
DRUGS | 1985年 / 29卷 / 04期
关键词：
D O I：
10.2165/00003495-198529040-00003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：342 / 375
页数：34
相关论文
共 230 条
  • [21] CARTWRIGHT RA, 1982, LANCET, V2, P842
  • [22] DRUGS AND GENES - THERAPEUTIC IMPLICATIONS
    CHAPMAN, CJ
    [J]. DRUGS, 1977, 14 (02) : 120 - 127
  • [23] EVIDENCE FOR A TRIMODAL PATTERN OF ACETYLATION OF ISONIAZID IN UREMIC SUBJECTS
    CHAPRON, DJ
    BLUM, MR
    KRAMER, PA
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (07) : 1018 - 1019
  • [24] KINETIC DISCRIMINATION OF 3 SULFAMETHAZINE ACETYLATION PHENOTYPES
    CHAPRON, DJ
    KRAMER, PA
    MERCIK, SA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) : 104 - 113
  • [25] RELATIONSHIP OF SULFAMETHAZINE DISPOSITION KINETICS TO ACETYLATOR PHENOTYPE IN MAN - PRELIMINARY-STUDY
    CHAPRON, DJ
    BLUM, MR
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (07) : 338 - 344
  • [26] POTENTIAL INFLUENCE OF BODY-WEIGHT ON THE CLEARANCE OF POLYMORPHICALLY ACETYLATED DRUGS
    CHAPRON, DJ
    KRAMER, PA
    MERCIK, SA
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (5-6) : 271 - 275
  • [27] CLARK DWJ, 1983, P U OTAGO MED SCH, V61, P30
  • [28] CLARK DWJ, 1984, CLIN EXPT PHARM PH S, V8, P67
  • [29] CLARK DWJ, 1984, BRIT J CLIN PHARM
  • [30] POLYMORPHICALLY ACETYLATED AMINOGLUTETHIMIDE IN HUMANS
    COOMBES, RC
    FOSTER, AB
    HARLAND, SJ
    JARMAN, M
    NICE, EC
    [J]. BRITISH JOURNAL OF CANCER, 1982, 46 (03) : 340 - 345
12345678910